or Try an Advanced Search...

    Antineoplastic Drugs Stocks List

    Symbol Grade Name % Change
    EFTR F eFFECTOR Therapeutics, Inc. 0.00
    PPBT F Purple Biotech Ltd. 2.83
    CLRB F Cellectar Biosciences, Inc. 0.32
    BNOX F Bionomics Limited -1.88
    HURA F TuHURA Biosciences, Inc. -0.60
    BFRI F Biofrontera Inc. -1.91
    HRTX F Heron Therapeutics, Inc. -4.91
    BYSI F BeyondSpring, Inc. 0.00
    STRO F Sutro Biopharma, Inc. -1.69
    IOVA F Iovance Biotherapeutics, Inc. 2.27
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic
    Related Stock Lists: Cancer Clinical Medicine Medicine Biopharmaceutical Cancer Treatment Chemotherapy Immunotherapy Oncology Occupational Safety And Health Solid Tumors Cancer Immunotherapy Checkpoint Inhibitor Immune System Melanoma Milatuzumab Pembrolizumab Stem Cell Actinic Keratosis Adjunctive Therapy Adoptive Cell Transfer

    Related ETFs - A few ETFs which own one or more of the above listed Antineoplastic Drugs stocks.

    Symbol Grade Name Weight
    JFWD B Jacob Funds Inc. Jacob Forward ETF 2.78
    CNCR F Loncar Cancer Immunotherapy ETF 2.42
    IDNA D iShares Genomics Immunology and Healthcare ETF 2.38
    WDNA D WisdomTree BioRevolution Fund 1.93
    BBP C BioShares Biotechnology Products Fund 1.48
    View all Antineoplastic Drugs ETFs...
    Compare ETFs
    Compare CNCR to BBP Compare CNCR to IDNA Compare JFWD to WDNA

        Antineoplastic Drugs Stocks Recent News

        Date Stock Title
        Nov 19 CLRB Q3 2024 Cellectar Biosciences Inc Earnings Call
        Nov 18 BNOX Bionomics files for $100M mixed securities shelf
        Nov 18 STRO Sutro Biopharma (STRO) Upgraded to Buy: Here's What You Should Know
        Nov 18 CLRB Cellectar Biosciences, Inc. (CLRB) Q3 2024 Earnings Call Transcript
        Nov 18 CLRB Cellectar Biosciences GAAP EPS of -$0.40 misses by $0.03
        Nov 18 CLRB Cellectar Biosciences Reports Financial Results for Q3 2024 and Provides a Corporate Update
        Nov 18 CLRB Earnings Scheduled For November 18, 2024
        Nov 15 CLRB Cellectar Biosciences Q3 2024 Earnings Preview
        Nov 15 PPBT Purple Biotech GAAP EPS of -$0.39
        Nov 15 PPBT Purple Biotech Reports Third Quarter 2024 Financial Results
        Nov 15 STRO Sutro Biopharma Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
        Nov 15 BFRI Biofrontera Inc (BFRI) Q3 2024 Earnings Call Highlights: Strategic Advancements Amidst Revenue ...
        Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic
        Related Stock Lists: Cancer Clinical Medicine Medicine Biopharmaceutical Cancer Treatment Chemotherapy Immunotherapy Oncology Occupational Safety And Health Solid Tumors Cancer Immunotherapy Checkpoint Inhibitor Immune System Melanoma Milatuzumab Pembrolizumab Stem Cell Actinic Keratosis Adjunctive Therapy Adoptive Cell Transfer
        Antineoplastic Drugs

        Antineoplastic drugs, also known as cytotoxic drugs, are a type of medication used to treat cancer. They work by interfering with the growth and spread of cancer cells. These drugs can be used alone or in combination with other treatments, such as surgery, radiation therapy, or hormone therapy.

        Browse All Tags